SEC Fines RIA Over Marketing Rule Violations

News December 23, 2024 at 01:37 PM
Share & Print

What You Need To Know

  • Atlas Financial Advisors was ordered to pay a $175,000 penalty.
  • Atlas falsely said the hypothetical performance of its "Portfolio Shield" investment strategies was verified and validated by Morningstar, according to the regulator.
  • Rather, the SEC says, an Atlas employee used Morningstar's software to calculate the hypothetical performance.
/contrib/content/uploads/sites/415/2021/03/SEC_Seal_Headquarters_BB_640x640.jpg

The Securities and Exchange Commission has ordered Atlas Financial Advisors to pay a $175,000 civil penalty for Marketing Rule violations, including making false and misleading statements that the hypothetical performance of its "Portfolio Shield" investment strategies was verified and validated by Morningstar.

Following the Nov. 4, 2022 compliance deadline for the Marketing Rule, Atlas made false and misleading claims about its investment strategies and their performance, failed to present net performance information alongside gross performance, was unable to substantiate performance claims upon demand by the SEC, and advertised hypothetical performance on its public website without adopting and implementing required policies and procedures, according to the SEC's order.

"Atlas also violated Advisers Act Rule 204-2(a)(16) by not maintaining books and records sufficient to demonstrate the calculation of the performance information in its advertisements, and Atlas violated Advisers Act Rule 206(4)-7 by failing to implement certain of its compliance policies and procedures," the order states.

Following the compliance date, Atlas disseminated material on its public websites that constituted advertisements and that contained false and misleading statements, the order states.

For example, "Atlas’ public website advertised its 'Portfolio Shield' investment strategies through statements and fact sheets that presented hypothetical performance derived from model portfolios, much of which was back-tested by applying the strategies to data from time periods prior to Portfolio Shield’s commencement in 2015," the SEC said.

"Atlas’ website claimed that this hypothetical performance was 'verified by Morningstar,' 'validated by Morningstar,' and that '[e]ach month Morningstar provides an updated Investment Detail Report on the Portfolio Shield Strategy,'" according to the order.

In fact, the order continues, "Morningstar, Inc. never verified Atlas’ calculations nor provided reports on the strategies. Rather, an Atlas employee used a software tool offered by Morningstar to calculate the advertised hypothetical performance."

Atlas’ website and fact sheets "also attributed hypothetical performance to the Portfolio Shield strategies without disclosing that the performance was calculated from model portfolios that did not consistently follow the strategies’ advertised investment formulas," the agency said.

"Atlas advertised Portfolio Shield as 'formula-based' strategies that involved potential investments in a discrete set of ETFs," according to the order.

"However, when Atlas selected the model portfolios that it used to calculate the strategies’ hypothetical performance, Atlas included investments in ETFs that were not disclosed as potential investments under the advertised strategies, the order stated. "As a result, most of the performance figures that Atlas attributed to Portfolio Shield in its post-Compliance Date advertisements were based on the performance of model portfolios that did not consistently follow the advertised strategies."

Atlas’ advertisements contained other false and misleading statements.

Atlas’ website "stated that the Portfolio Shield strategies 'at all times' invested in ETFs that used a 'systematic options overlay,'" according to the order.

"In fact, at all times since the Compliance Date, the Portfolio Shield strategies did not use an options overlay or invest in any ETFs that used one," the SEC said.

Credit: Bloomberg

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Resource Center